Roche's Lucentis Could Get Boost From House Compounding Directives To FDA
Executive Summary
Compounding pharmacies – and makers of particular products – would see favorable guidance changes under instructions to FDA in House appropriations report.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
No comments:
Post a Comment